Evidence map›Paper›PMID 37488468›Full record

ReviewAnnals of biomedical engineering2023

Generative Adversarial Networks in Medicine: Important Considerations for this Emerging Innovation in Artificial Intelligence.

Phani Srivatsav Paladugu, Joshua Ong, Nicolas Nelson, Sharif Amit Kamran, Ethan Waisberg, Nasif Zaman, Rahul Kumar, Roger Daglius Dias, Andrew Go Lee, Alireza Tavakkoli

Abstract readReview
PubMed Publisher
In one paragraph

Review in Annals of biomedical engineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Applications of generative adversarial networks in the diagnosis, prognosis, and treatment of ophthalmic diseases.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Quantum biology in ophthalmology.Eye (London, England) · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Phani Srivatsav PaladuguBrigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Joshua OngMichigan Medicine, University of Michigan, Ann Arbor, MI, USA.
Nicolas NelsonSidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Sharif Amit KamranHuman-Machine Perception Laboratory, Department of Computer Science and Engineering, University of Nevada, Reno, Reno, NV, USA.
Ethan WaisbergUniversity College Dublin School of Medicine, Belfield, Dublin, Ireland.
Nasif ZamanHuman-Machine Perception Laboratory, Department of Computer Science and Engineering, University of Nevada, Reno, Reno, NV, USA.
Rahul KumarUniversity of Miami, Coral Gables, FL, USA.
Roger Daglius DiasDepartment of Emergency Medicine, Harvard Medical School, Boston, MA, USA.
Andrew Go LeeCenter for Space Medicine, Baylor College of Medicine, Houston, TX, USA.
Alireza TavakkoliHuman-Machine Perception Laboratory, Department of Computer Science and Engineering, University of Nevada, Reno, Reno, NV, USA. tavakkol@unr.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The advent of artificial intelligence (AI) and machine learning (ML) has revolutionized the field of medicine. Although highly effective, the rapid expansion of this technology has created some anticipated and unanticipated bioethical considerations. With these powerful applications, there is a necessity for framework regulations to ensure equitable and safe deployment of technology. Generative Adversarial Networks (GANs) are emerging ML techniques that have immense applications in medical imaging due to their ability to produce synthetic medical images and aid in medical AI training. Producing accurate synthetic images with GANs can address current limitations in AI development for medical imaging and overcome current dataset type and size constraints. Offsetting these constraints can dramatically improve the development and implementation of AI medical imaging and restructure the practice of medicine. As observed with its other AI predecessors, considerations must be taken into place to help regulate its development for clinical use. In this paper, we discuss the legal, ethical, and technical challenges for future safe integration of this technology in the healthcare sector.

Indexed as

Artificial IntelligenceMachine LearningTechnologyAIArtificial intelligenceBioethicsClinical medicineGeneral adversial networksHealthcareMachine learningMedical educationMedical imaging

Identifiers

PMID37488468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.